investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer

Tzyy-Choou Wu

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Tzyy-Choou Wu

Johns Hopkins University

Baltimore, United States

Related projects

Patrick J Loehrer

AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS

Cervix uteri

Michael S Saag

UAB Center for AIDS Research

Non-Hodgkin lymphoma Kaposi sarcoma Cervix uteri

Lenine Julie Phillips Liebenberg

Immune mediators associated with HPV clearance as predictors of HIV acquisition

Cervix uteri

Kathleen Schmeler

Improving Cervical Cancer Screening and Prevention in Zambia, Mozambique, and South Africa with Project ECHO telementoring

Cervix uteri

Global Noncommunicable Diseases Intiatives

Development of Low-Cost HPV Vaccine and WHO PQ [PDW] - 2

Cervix uteri

Douglas D Richman

Center for AIDS Research

Kaposi sarcoma Colorectum Cervix uteri Brain, nervous system

Anna Wald

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

Cervix uteri

Sylvia Silver

The East Coast Aids and Cancer Specimen Resource

Trachea, bronchus and lung Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Cervix uteri

Robert Garcea

SPORE in Cervical Cancer - Project 1: L1 Capsomeres as a Next Generation Preventative Vaccine

Cervix uteri